SEVERE WX : Air Stagnation Advisory View Alerts

Moderna urges FDA to authorize a half-size booster dose of its Covid-19 vaccine for some adults

The FDA's Vaccines and Related Biological Products Advisory Committee is meeting this week to consider booster doses of the Moderna and Johnson & Johnson Covid-19 vaccines.

Posted: Oct 12, 2021 12:49 PM

By Jamie Gumbrecht, CNN

(CNN) -- Moderna is urging the US Food and Drug Administration to authorize a half-size booster of its Covid-19 vaccine, according to a briefing document posted Tuesday, ahead of a key meeting of the agency's vaccine advisers.

The company is asking for authorization for a 50-microgram booster dose -- half the size of the 100-microgram doses used in the primary series of the two-dose vaccine. The company says halving the dose increases protection against the coronavirus while helping the worldwide Covid-19 vaccine supply.

The FDA's Vaccines and Related Biological Products Advisory Committee is meeting this week to consider booster doses of the Moderna and Johnson & Johnson Covid-19 vaccines. The FDA previously authorized boosters of Pfizer's Covid-19 vaccine for some adults.

Moderna is requesting authorization for a 50-microgram booster dose at least six months after the second dose for certain groups: people age 65 and older; people ages 18 to 64 who are at high risk of severe Covid-19; and people ages 18 to 64 whose exposure to the coronavirus in their settings or jobs put them at risk for Covid-19 complications or severe illness.

Antibodies have been shown to wane several months after people complete their Moderna or Pfizer vaccine series, but protection against severe disease and death remain strong after two doses. However, Moderna says, trial data and real-world evidence "support interventions to restore or enhance" antibodies that have waned over time.

"Clinical trial data breakthrough infections as well as real world evidence of reduced effectiveness against the Delta variant indicate that a booster dose of mRNA-1273 for those vaccinated more than 6 months previously could be beneficial to restore antibody titers to higher than post-dose 2 levels and reduce the number of breakthrough cases particularly against (variants of concern)," Moderna said in its briefing document.

Moderna's authorization request includes results from a study of 171 people who received the authorized 100-microgram doses of Moderna's vaccine and a 50-microgram booster dose at least six months later. Moderna also included safety data from another group of Moderna trial participants.

Efficacy against symptomatic Covid-19 wasn't evaluated among booster dose recipients, the FDA notes in its analysis released Tuesday.

Just as with Pfizer's booster dose submission, the FDA did not take a position on EUA for a booster dose of Moderna's vaccine in its VRBPAC briefing document.

"The expected benefit of booster vaccination will depend on the impact that booster vaccination has in reducing disease relative to the primary series," the FDA's analysis said. "If the primary series of Moderna COVID19 Vaccine is still effective in preventing important COVID-19-related outcomes, then the benefit of booster vaccination is likely to be more limited than if effectiveness following the primary series has waned substantially."

It said factors to consider include effectiveness of the primary series over time and against variants in circulation, the effectiveness of a booster against outcomes such as death, hospitalization and long Covid, the dynamics of the pandemic in the United States and the risks of a booster dose.

"Some real world effectiveness studies have suggested declining efficacy of Moderna COVID-19 Vaccine over time against symptomatic infection or against the Delta variant, while others have not," the agency's analysis said. "However, overall, data indicate that currently US-licensed or authorized COVID-19 vaccines still afford protection against severe COVID-19 disease and death in the United States. There are many potentially relevant studies, but FDA has not independently reviewed or verified the underlying data or their conclusions."

Moderna booster safety
In addition to effectiveness, the briefing documents included some details about safety of booster doses of Moderna's vaccine.

The two-dose mRNA Covid-19 vaccines made by Moderna and Pfizer have been linked to rare cases of heart inflammation, particularly among younger men. Studies have found such myocarditis and pericarditis cases are generally mild.

The FDA's analysis notes that trials conducted before authorization might not be large enough to fully understand uncommon, potentially serious adverse reactions to a booster dose.

"It is currently not known if there will be an increased risk of myocarditis/pericarditis or other adverse reactions after a booster dose of the Moderna COVID-19 Vaccine," the FDA's analysis says. "These risks and associated uncertainties have to be considered when assessing benefit and risk."

There was a higher rate of swollen lymph nodes after the booster dose when compared with the second dose in the primary Moderna series, but safety data didn't otherwise show increased frequency or severity of reactions after a booster dose.

What happens next?
On Thursday, the FDA's independent vaccine advisers are expected to discuss and vote on whether to recommend authorization of boosters for the Moderna Covid-19 vaccine.

On Friday, the advisers are scheduled to discuss and vote on whether to recommend authorization of boosters for Johnson & Johnson's Covid-19 vaccine.

Both vaccines are already authorized for use in people age 18 and older.

VRBPAC members will also hear a presentation on Friday on "mix and match" booster doses.

The committee of independent advisers typically discusses and makes recommendations to the FDA about vaccine authorizations and approvals, and the agency then makes the final decision about whether to OK vaccines. If they're authorized, the CDC's vaccines advisers are scheduled to meet October 20-21 to discuss whether to recommend them for use.

Oregon Coronavirus Cases

Data is updated nightly.

Cases: 391099

Reported Deaths: 5161
CountyCasesDeaths
Multnomah60298839
Washington41981395
Marion39886506
Clackamas32773378
Lane30113355
Jackson24880360
Deschutes23557185
Umatilla15126180
Linn14637179
Douglas13375291
Josephine10148244
Yamhill9762143
Klamath9053146
Polk8212100
Benton609738
Malheur592487
Coos5664106
Columbia430455
Jefferson420266
Lincoln362152
Union338755
Crook334056
Wasco316146
Clatsop261835
Baker219833
Tillamook216645
Hood River213737
Morrow197525
Curry191939
Harney119933
Grant108515
Lake105416
Wallowa75713
Sherman1913
Gilliam1854
Wheeler1141
Unassigned00

California Coronavirus Cases

Data is updated nightly.

Cases: 5083462

Reported Deaths: 74473
CountyCasesDeaths
Los Angeles152713227166
San Diego4069274335
Riverside3876785358
San Bernardino3745435962
Orange3343985725
Sacramento1683542443
Kern1576621804
Fresno1567952254
Santa Clara1520891925
Alameda1251761504
San Joaquin1075591834
Ventura1040031190
Contra Costa1037721046
Stanislaus915481417
Tulare860871096
San Francisco56909669
San Mateo56320629
Monterey52488626
Solano47671357
Santa Barbara47293549
Merced45053667
Sonoma43168412
Placer42141470
Imperial38477773
Kings35206363
San Luis Obispo31476359
Madera26194311
Shasta26081451
Butte25455314
Santa Cruz22248224
Yolo21558257
Marin18465249
El Dorado18301166
Sutter14571186
Napa13420104
Yuba1076089
Tehama10275130
Humboldt10158119
Nevada10019105
Mendocino857197
Lassen796756
San Benito781578
Tuolumne773090
Lake7043110
Amador577366
Siskiyou474755
Glenn457436
Calaveras441588
Del Norte375542
Colusa325220
Inyo256646
Plumas19367
Mono18784
Mariposa160018
Trinity99717
Modoc7655
Unassigned3220
Sierra2180
Alpine1080
Out of CA00
Medford
Cloudy
43° wxIcon
Hi: 48° Lo: 40°
Feels Like: 43°
Brookings
Partly Cloudy
59° wxIcon
Hi: 64° Lo: 45°
Feels Like: 59°
Crater Lake
Partly Cloudy
43° wxIcon
Hi: 47° Lo: 29°
Feels Like: 43°
Grants Pass
Cloudy
43° wxIcon
Hi: 48° Lo: 43°
Feels Like: 43°
Klamath Falls
Partly Cloudy
30° wxIcon
Hi: 52° Lo: 28°
Feels Like: 30°
Stagnant and dry weather continue all week
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events